Madrigal Pharmaceuticals Senior VP Executes Major Stock Transactions
June 12, 2024 was a notable day for Madrigal Pharmaceuticals, Inc. as Robert E. Waltermire, Senior Vice President and Chief of Pharmaceutical Development, sold 2,000 shares of common stock at an average price of $285 per share, amounting to a total of $570,000.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
